153 related articles for article (PubMed ID: 10360970)
21. Construction of a novel vaccine by conjugating a B-cell epitope of DPP4 to peptide IA2(5)-P2-1 to significantly control type 1 diabetes in NOD mice.
Li Y; Cao H; Li Y; Li Z; Wei X; Jiao R; Cheng P; Liu X; Ma Y; Xing Y; Tang J; Wang M; Li T
Vaccine; 2017 Dec; 35(51):7187-7197. PubMed ID: 29169891
[TBL] [Abstract][Full Text] [Related]
22. T cell reactivity to heat shock protein 60 in diabetes-susceptible and genetically protected nonobese diabetic mice is associated with a protective cytokine profile.
van Halteren AG; Mosselman B; Roep BO; van Eden W; Cooke A; Kraal G; Wauben MH
J Immunol; 2000 Nov; 165(10):5544-51. PubMed ID: 11067908
[TBL] [Abstract][Full Text] [Related]
23. DNA vaccination with heat shock protein 60 inhibits cyclophosphamide-accelerated diabetes.
Quintana FJ; Carmi P; Cohen IR
J Immunol; 2002 Nov; 169(10):6030-5. PubMed ID: 12421990
[TBL] [Abstract][Full Text] [Related]
24. Prevention of diabetes in the NOD mouse by a Th1 clone specific for a hsp60 peptide.
Feili-Hariri M; Frantz MO; Morel PA
J Autoimmun; 2000 Mar; 14(2):133-42. PubMed ID: 10677244
[TBL] [Abstract][Full Text] [Related]
25. Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice.
Arai T; Moriyama H; Shimizu M; Sasaki H; Kishi M; Okumachi Y; Yasuda H; Hara K; Yokono K; Nagata M
Clin Immunol; 2010 Jul; 136(1):74-82. PubMed ID: 20359955
[TBL] [Abstract][Full Text] [Related]
26. Spontaneous development of protective anti-T cell receptor autoimmunity targeted against a natural EAE-regulatory idiotope located within the 39-59 region of the TCR-V beta 8.2 chain.
Hashim GA; Offner H; Wang RY; Shukla K; Carvalho E; Morrison WJ; Vandenbark AA
J Immunol; 1992 Oct; 149(8):2803-9. PubMed ID: 1401912
[TBL] [Abstract][Full Text] [Related]
27. A cross-reactive idiotope on T cells from PL/J mice and Lewis rats that recognizes different myelin basic protein encephalitogenic epitopes but is restricted by TCR V beta 8.2.
Zhou SR; Whitaker JN; Han Q; Maier C; Blalock JE
J Immunol; 1994 Sep; 153(5):2340-51. PubMed ID: 7519648
[TBL] [Abstract][Full Text] [Related]
28. Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome.
Kern J; Drutel R; Leanhart S; Bogacz M; Pacholczyk R
PLoS One; 2014; 9(11):e112467. PubMed ID: 25379761
[TBL] [Abstract][Full Text] [Related]
29. The pathogenicity of islet-infiltrating lymphocytes in the non-obese diabetic (NOD) mouse.
Ablamunits V; Elias D; Cohen IR
Clin Exp Immunol; 1999 Feb; 115(2):260-7. PubMed ID: 9933451
[TBL] [Abstract][Full Text] [Related]
30. Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial.
Raz I; Elias D; Avron A; Tamir M; Metzger M; Cohen IR
Lancet; 2001 Nov; 358(9295):1749-53. PubMed ID: 11734230
[TBL] [Abstract][Full Text] [Related]
31. Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide-specific regulatory CD4 T cells.
Kumar V; Sercarz E
J Immunol; 1998 Dec; 161(12):6585-91. PubMed ID: 9862685
[TBL] [Abstract][Full Text] [Related]
32. Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein.
Elias D; Markovits D; Reshef T; van der Zee R; Cohen IR
Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1576-80. PubMed ID: 2406723
[TBL] [Abstract][Full Text] [Related]
33. T cell proliferative responses of type 1 diabetes patients and healthy individuals to human hsp60 and its peptides.
Abulafia-Lapid R; Elias D; Raz I; Keren-Zur Y; Atlan H; Cohen IR
J Autoimmun; 1999 Mar; 12(2):121-9. PubMed ID: 10047432
[TBL] [Abstract][Full Text] [Related]
34. Fusion protein His-Hsp65-6IA2P2 prevents type 1 diabetes through nasal immunization in NOD Mice.
Lu S; Li G; Liu K; Yang X; Cao R; Zong L; Long J; Jin L; Wu J
Int Immunopharmacol; 2016 Jun; 35():235-242. PubMed ID: 27082999
[TBL] [Abstract][Full Text] [Related]
35. Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide.
Alleva DG; Gaur A; Jin L; Wegmann D; Gottlieb PA; Pahuja A; Johnson EB; Motheral T; Putnam A; Crowe PD; Ling N; Boehme SA; Conlon PJ
Diabetes; 2002 Jul; 51(7):2126-34. PubMed ID: 12086942
[TBL] [Abstract][Full Text] [Related]
36. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
[TBL] [Abstract][Full Text] [Related]
37. T cells to a dominant epitope of GAD65 express a public CDR3 motif.
Quinn A; McInerney M; Huffman D; McInerney B; Mayo S; Haskins K; Sercarz E
Int Immunol; 2006 Jun; 18(6):967-79. PubMed ID: 16641112
[TBL] [Abstract][Full Text] [Related]
38. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein.
Elias D; Reshef T; Birk OS; van der Zee R; Walker MD; Cohen IR
Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3088-91. PubMed ID: 1707531
[TBL] [Abstract][Full Text] [Related]
39. [Improved efficacy of P277 fused to heat shock protein 65 of Mycobacterium tuberculosis against diabetes in nonobese diabetic mice].
Zhu A; Lu Y; Jin L; Wu J; Li T; Liu J
Sheng Wu Gong Cheng Xue Bao; 2008 Apr; 24(4):640-5. PubMed ID: 18616176
[TBL] [Abstract][Full Text] [Related]
40. The Th1/Th2 dichotomy, hsp60 autoimmunity, and type I diabetes.
Cohen IR
Clin Immunol Immunopathol; 1997 Aug; 84(2):103-6. PubMed ID: 9245539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
